Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5274Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Holtmann, Gerald | en |
| dc.contributor.author | Schrenk, Dietmar | en |
| dc.contributor.author | Madisch, Ahmed | en |
| dc.contributor.author | Allescher, Hans D | en |
| dc.contributor.author | Ulrich-Merzenich, Gudrun | en |
| dc.contributor.author | Mearin, Fermin | en |
| dc.contributor.author | Larrey, Dominique | en |
| dc.contributor.author | Malfertheiner, Peter | en |
| dc.date.accessioned | 2023-06-26T03:02:40Z | - |
| dc.date.available | 2023-06-26T03:02:40Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.uri | https://dora.health.qld.gov.au/qldresearchjspui/handle/1/5274 | - |
| dc.description.abstract | Herbal or complementary medicines are frequently used for the treatment of patients with functional gastrointestinal disorders (FGID). Regulatory requirements for herbal therapies are inconsistent and, in many jurisdictions, herbal therapies are either self-, minimally- or unregulated. | en |
| dc.language.iso | en | en |
| dc.relation.ispartof | Digestive diseases (Basel, Switzerland) | en |
| dc.title | Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches | en |
| dc.type | Article | en |
| dc.identifier.doi | 10.1159/000504570 | - |
| dc.identifier.pmid | 31770769 | - |
| dc.rights.holder | Holtmann, Gerald | en |
| item.cerifentitytype | Publications | - |
| item.openairetype | Article | - |
| item.fulltext | No Fulltext | - |
| item.grantfulltext | none | - |
| item.languageiso639-1 | en | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| Appears in Sites: | Gastroenterology and Hepatology, Princess Alexandra Hospital | |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.